The presence of one to four circulating tumor cells (CTCs) in the blood of early-stage breast cancer patients almost doubled patient's risk of cancer relapse and death, and five or more CTCs increased recurrence by 400 percent and death by 300 percent, according to Phase III results of the SUCCESS trial. These cells were found in patients after surgery but before chemotherapy treatment.
- Circulating tumor cells predicted recurrence, death in patients with early-stage breast cancerFri, 10 Dec 2010, 14:34:43 EST
- Early-stage, HER2-positive breast cancer patients at increased risk of recurrenceMon, 2 Nov 2009, 19:10:54 EST
- Early stage, HER2-positive breast cancer patients at increased risk of recurrenceFri, 12 Dec 2008, 13:15:26 EST
- Diet may cut second breast cancers in women without hot flashesTue, 16 Dec 2008, 5:08:27 EST
- Poor breast cancer prognosis associated with presence of circulating tumor, cancer stem cellsFri, 10 Dec 2010, 14:34:38 EST